Insurmountable angiotensin AT1 receptor antagonists : the role of tight antagonist binding

• Published in: European journal of pharmacology 1999-05, Vol.372 (2), p.199-206
• Main Authors: FIERENS, F. L. P, VANDERHEYDEN, P. M. L, DE BACKER, J.-P, VAUQUELIN, G
• Format: Article
• Language: English
• Subjects: Angiotensin II - metabolism; Angiotensin Receptor Antagonists; Animals; Antihypertensive agents; Antihypertensive Agents - pharmacology; Benzimidazoles - pharmacology; Binding, Competitive - drug effects; Biological and medical sciences; Biphenyl Compounds - pharmacology; Cardiovascular system; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Imidazoles - pharmacology; Irbesartan; Losartan - pharmacology; Medical sciences; Pharmacology. Drug treatments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin - agonists; Recombinant Proteins - metabolism; Tetrazoles - pharmacology
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/s0014-2999(99)00205-8

Angiotensin II increased the inositol phosphates production (EC50 = 3.4+/-0.7 nM) in Chinese hamster ovary (CHO) cells expressing the cloned human angiotensin AT1 receptor (CHO-AT1 cells). Coincubation with angiotensin AT1 receptor antagonists produced parallel rightward shifts of the concentration-response curve without affecting the maximal response. The potency order is 2-ethoxy-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1H-benz imidazoline-7-carboxylic acid (candesartan) > 2-n-butyl-4-chloro-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]i midazole-5-carboxylic acid (EXP3174) > 2-n-butyl-4-spirocyclopentane-1-[(2'-(1H-tetrazol-5-yl)biphe nyl-4-yl)methyl]2-imidazolin-5-one (irbesartan)> of 2-n-butyl-4-chloro-5-hydroxymethyl-1-(2'-(1H-tetrazol-5-yl)bipheny l-4-yl)methyl]imidazole (losartan). Additionally, preincubation with these antagonists depressed the maximal response, i.e., 95%, 70%, 30% of the control response for candesartan, EXP3174 and irbesartan and not detectable for losartan. Increasing the antagonist concentration or prolonging the preincubation time did not affect this depression. Furthermore, these values remained constant for candesartan and EXP3174, when the angiotensin II incubation time varied between 1 and 5 min. Our data indicate that antagonist-receptor complexes are divided into a fast reversible/surmountable population and a tight binding/insurmountable population at the very onset of the incubation with angiotensin II.